NCT07215130Recruiting
Selective Removal of Endometriotic Lesions Using CUSA Clarity in Ovarian Endometriomas
Selective Removal of Endometriotic Lesions Using CUSA Clarity in Ovarian Endometriomas: A Case-Based Histopathological Study
Source: ClinicalTrials.gov · Last updated 10 Oct 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study aims to evaluate the feasibility and tissue selectivity of a novel surgical technology, the Cavitron Ultrasonic Surgical Aspirator (CUSA) Clarity, in the management of ovarian endometriomas. Ovarian endometriomas are cysts caused by endometriosis that can damage ovarian reserve when treated by conventional surgery. In this study, ovarian cyst wall specimens are examined ex vivo using different Tissue Select settings of the CUSA device. Histopathological analyses are performed to determine whether endometriotic epithelium can be selectively removed while preserving normal ovarian tissue. The findings may contribute to developing fertility-preserving surgical approaches for women with endometriomas.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 10 (estimated)
- First submitted
- 1 Oct 2025
- Start date
- 30 Jan 2025
- Primary completion date
- 31 Mar 2027
- Lead sponsor
- Kanazawa University
- Diseases
- Endometriosis
- NCT number
- NCT07215130
What you commit to
- Study type: Observational
- Planned participants: 10
- From 30 Jan 2025 to the primary completion date, 31 Mar 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with suspected malignancy based on preoperative imaging.
Other
- Patients judged by the attending physician to be unsuitable for participation in this study for any reason.
Who the study is looking for
- Female patients diagnosed with ovarian endometrioma who undergo surgical treatment (cystectomy or adnexectomy) at Kanazawa University Hospital between January 1, 2025, and March 31, 2027.
- Written informed consent obtained prior to study participation.
- Age ≥ 20 years at the time of consent.
- For patients with previously stored endometrioma specimens under a broad consent, additional written consent for participation in this study will be obtained.
Age in the registry: 20 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Kanazawa University Hospital Coordinator of this site? Confirm its status | Kanazawa | Japan | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.